Comparison of Six versus Three Doses of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Randomized Controlled Trial
Indian Journal of Pediatrics · 2025
DOI: 10.1007/s12098-024-05405-6 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Pediatrics, 2025. Verfasst von Bisman Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India. Hauptthemen laut MEDLINE: Streptokinase, Empyema, Pleural, Fibrinolytic Agents, Thrombolytic Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVES: To compare six doses of intrapleural streptokinase (SK) vs. the conventional three doses in children with empyema. METHODS: In this randomized controlled trial, children with empyema received intrapleural streptokinase, either twice daily for 3 d (total 6 doses); or once daily for 3 d (total 3 doses). The outcomes assessed were treatment failure, volume of fluid drained, duration of fever, duration of respiratory distress, length of hospitalization, need for surgical decortication, adverse events and cost. RESULTS: Thirty-six children were enrolled. Cumulative pleural pus drainage was significantly higher with six doses [median (IQR) 367 (266, 850) vs. 195 (142, 422) ml, p 0.02]. The mean (SD) durations of fever and respiratory distress, after completing intrapleural therapy were also shorter; 2.3 (0.8) vs. 5.7 (1.6) d, p 0.04; and 2.2 (0.9) vs. 6.3 (1.9) d, p 0.03 respectively. However, there were no statistically significant differences in the length of hospitalization after completing therapy [median (IQR) 9 (6, 17) vs. 12 (4, 16) d], total duration of intercostal drainage [median (IQR) 13 (11, 21) vs. 12 (7, 19) d], treatment failure rate [4/16 (25%) vs. 7/16 (43.7%)], or need for surgical decortication [2/16 (16.2%) vs. 1/16 (6.2%)]. There were no significant adverse effects necessitating cessation or modification of therapy in either group. The cost of therapy was identical in both groups. CONCLUSIONS: Six doses of intrapleural streptokinase appear superior to the conventional three doses in children with empyema, with comparable safety and cost.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
- Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India. dr.joseph.l.mathew@gmail.com.
- Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Joseph L Mathew
Zitieren
APA
Singh, B., Mathew, J. L., Jayashree, M., Saxena, A. K., & Ray, P. (2025). Comparison of Six versus Three Doses of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Randomized Controlled Trial. Indian Journal of Pediatrics. https://doi.org/10.1007/s12098-024-05405-6
Vancouver
Singh B, Mathew JL, Jayashree M, Saxena AK, Ray P. Comparison of Six versus Three Doses of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Randomized Controlled Trial. Indian Journal of Pediatrics. 2025. doi:10.1007/s12098-024-05405-6
BibTeX
@article{Singh2025,
author = {Singh, Bisman and Mathew, Joseph L and Jayashree, Muralidharan and Saxena, Akshay K and Ray, Pallab},
title = {Comparison of Six versus Three Doses of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Randomized Controlled Trial},
journal = {Indian Journal of Pediatrics},
year = {2025},
doi = {10.1007/s12098-024-05405-6}
}
EUVIMED